PLIANT THERAPEUTICS, INC. (PLRX) Total liabilities 2019–2025
PLIANT THERAPEUTICS, INC. (PLRX) total liabilities at each fiscal year-end, per SEC filings.
$44.0MFY2025 · since FY2019: $9.1M → $44.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.0M | -52.6% |
| FY2024 | $92.9M | +140.7% |
| FY2023 | $38.6M | +3.5% |
| FY2022 | $37.3M | +68.2% |
| FY2021 | $22.2M | +77.7% |
| FY2020 | $12.5M | +37.2% |
| FY2019 | $9.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PLRX financial trends
PLRX RevenuePLRX Net incomePLRX Net marginPLRX Gross profitPLRX Gross marginPLRX Operating incomePLRX Operating marginPLRX Operating cash flowPLRX Free cash flowPLRX Capital expendituresPLRX Return on equityPLRX Stock buybacksPLRX Dividends paidPLRX Total assetsPLRX Shareholders’ equityPLRX overview →